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Mild iodine deficiency and thyroid
disorders in Hong Kong
Objectives. To review evidence of iodine deficiency and clinical thyroid
disorders in Hong Kong.
Data sources. Publications on local dietary iodine intake, the iodine
content of local food items, and clinical thyroid problems in the Hong
Kong population.
Data extraction. Data was extracted and evaluated independently by the
authors.
Data synthesis. Iodine is an essential nutrient. Iodine deficiency can lead
to goitre, hypothyroidism, mental deficiency, and impaired growth. It is
now appreciated that determination of goitre incidence in children alone
may grossly underestimate the problem of iodine deficiency in a
population. In total, the evidence indicates that iodine deficiency exists
in Hong Kong, leading to clinical problems of transient neonatal hypo-
thyroidism, goitrogenesis, and thyroid disorders in pregnant women and
neonates, as well as thyroid dysfunction in the elderly.
Conclusion. A supplementation programme aimed at a relatively uniform
iodine intake is recommended to avoid deficient or excessive iodine intake
in subpopulations.
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Introduction
Iodine is an important trace element and an essential substrate for the
synthesis of thyroid hormones. The two major thyroid hormones, triiodo-
thyronine (T3) and tetraiodothyronine (T4), are iodinated molecules which
exert diverse effects on cellular metabolism, growth, and development.
Due to the importance of thyroid hormone–dependent processes, iodine
deficiency has deleterious effects on individuals, especially pregnant
women and growing children. The clinical and subclinical manifestations
of iodine deficiency are collectively referred to as iodine deficiency
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disorders (IDD). Iodine deficiency disorder is a serious
global public health problem, estimated to affect one
billion people worldwide.1 Dietary iodine deficiency
is the major cause of intellectual deficit worldwide.2-4
In areas of endemic goitre and cretinism, the problem
of iodine deficiency is not difficult to recognise.
However, it has been realised only in recent years that
milder forms of iodine insufficiency exist in non-
goitrous areas, presenting in a more subtle manner—
with increased pregnancy loss, increased perinatal and
infant mortality, neonatal hyperthyrotropinaemia,
neonatal hypothyroidism, growth retardation, and
intellectual disability in children.5
Since the establishment of the International Council
for Control of Iodine Deficiency Disorders in 1986,
there has been greatly increased awareness of iodine
deficiency as a major preventable cause of mental
retardation. The World Health Organisation (WHO)
aimed to eliminate IDD by the year 2000. Its recom-
mended daily iodine intake levels are:
• at least 90 µg for children of 0-59 months;
• 120 µg for children aged 6-9 years;
• 150 µg for individuals older than 12 years, adoles-
cents and adults; and
• 200 µg for pregnant and lactating women.6
Recent reports have shown that, with the exception
of Japan, various degrees of dietary iodine deficiency
exist in South-East Asia.7 It has been estimated that
40% of individuals with IDD worldwide live in China,
especially in the mountainous and inland regions.8 To
eliminate IDD, the most common and widely used
intervention is iodine supplementation, using salt as
the vehicle.9 Salt iodisation involves the addition of a
small amount of iodine (20-100 mg of iodine per kg
of salt, or parts per million [ppm]). Added iodine is in
the form of potassium iodate rather than potassium
iodide, due to the greater stability of the former,10
particularly in countries with warm, damp, or tropical
climates. Research has shown that supplementation by
salt iodisation in populations with IDD results in
effective clinical improvement and considerable
reduction in all manifestations of IDD, including
cretinism and goitre.11,12 Furthermore, salt iodisation
has been proven to be extremely cost-effective, at
approximately US$0.5 per person per year. Currently,
75% of affected countries worldwide have legislation
relating to iodisation of salt, and 68% of affected
populations have access to iodised salt. In China,
legislation allowing iodisation of salt was passed in
1996, and in southern China and Guangzhou, salt has
since been iodised at 20-50 ppm, with the aim of
retention of 20 ppm at the consumers’ level.13
Hong Kong—a coastal city in southern China—is
not an endemic goitrous area, and IDD is not known
to be prevalent. Most of the salt supply in Hong
Kong comes from the southern provinces of China. A
recent survey conducted by the Hong Kong Consumer
Council of local brands of salt sold in supermarkets
and grocery stores, showed either no iodisation or low
levels of iodisation, however.14 It is generally believed
that iodine deficiency as a cause of clinical thyroid
problems does not exist in Hong Kong, an affluent
city with a plentiful supply of seafood. There is
circumstantial contradictory evidence refuting this
belief, however. This paper reviews the current situ-
ation with respect to iodine intake and thyroid
dysfunction in Hong Kong.
Iodine intake in Hong Kong
To determine whether IDD exists in Hong Kong, it
would be necessary to document the dietary iodine
intake of the Hong Kong population. The lack of
detailed information on iodine content for most
Chinese food items, however, makes estimation of
dietary intake difficult. Urinary iodine estimation is
an accepted alternative to determine the iodine intake
of a population.6 Using a cut-off value for fasting urine
iodine concentration of 0.79 µmol/L (100 µg/L), it
was found that 45.3% of children, 51.7% of adults,
and 55.3% of the elderly in Hong Kong had urine iodine
concentrations below this criterion.15 Fasting urine
concentrations below 0.79 µmol/L are defined by the
WHO as a state of iodine insufficiency.
Two surveys investigating the urine iodine excretion
of children in Hong Kong have also been completed.
One conducted in 1995 to 1996, showed a median
value of 0.96 µmol/L (121 µg/L),15 while the other,
performed in 1996 to 1997, showed a median value of
190 µg/L.16 These values are on the whole higher than
those reported for adults in Hong Kong. This is prob-
ably due to the different eating habits of children,
which lead to a comparative increase in iodine intake.
For example, children’s intake of iodine may be higher
due to the fortification of iodine in milk (at the level of
40 to 50 ppm), the consumption of roasted seaweed as
snacks, and the increase in the popularity of Japanese
foods, such as sushi and seaweed rolls, in this age-
group.
Transient neonatal hypothyroidism
A pointer to possible dietary iodine insufficiency in
Hong Kong is the high percentage of newborns with
elevated cord blood thyroid stimulating hormone
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(TSH) values, and the high incidence of transient
neonatal hypothyroidism. One of the parameters for
iodine deficiency is the incidence of elevated TSH in
newborn babies.6 The neonatal thyroid screening
programme, determining cord blood TSH level, was
launched in 1982 in Hong Kong. This programme
was initiated at the Queen Mary Hospital17 and
subsequently extended by the Clinical Genetic Service
of the Department of Health in 1984, to include all
hospitals in Hong Kong. Data from this programme
initially revealed that the mean cord blood TSH value
was 7.0 mU/L. Fifty percent of neonates had a cord
blood TSH level greater than 5.6 mU/L and approxi-
mately 22% of neonates had a cord blood TSH value
greater than 10 mU/L (equivalent to a whole blood
TSH value of 5 mU/L).17 The high incidence of elevated
cord blood TSH values in neonates in Hong Kong has
not changed over the past two decades. In iodine-
sufficient or iodine-replenished areas, the percentage
of babies with elevated TSH values (>5 mU/L in whole
blood samples) detected through neonatal screening
programmes is less than 3%.6
It is now appreciated that both neonatal thyroid
function and neonatal TSH level serve as very good
indices of the iodine supply for the population as a
whole, since newborns are more sensitive than adults
to iodine deficiency.6,18 In Europe, where mild-to-
moderate iodine deficiency exists in some countries,
the incidence of transient primary hypothyroidism is
six times higher than that observed in the US where
salt is iodised.19,20 In Hong Kong, approximately 23%
of the cases of congenital hypothyroidism detected by
the Neonatal Thyroid Screening programme were
transient in nature.17,21 At Queen Mary Hospital, with
a cord blood TSH level >25 mU/L used as the cut-off,
retesting was indicated in approximately 1.5% of
screened neonates. Infants with transient congenital
hypothyroidism had a low serum T4 level, and a TSH
level >40 mU/L on the confirmatory blood sample or
a TSH level between 20 and 40 mU/L on three
occasions. These children were treated with thyroid-
replacement therapy but were able to maintain normal
thyroid function when thyroxine treatment was
routinely withdrawn in order to reconfirm the diagnosis
at the age of 3 years. The cause of this transient neonatal
hypothyroidism was not attributed to transplacental
transfer of inhibitory TSH-receptor antibodies.22 In
iodine-sufficient areas, the incidence of transient
neonatal hypothyroidism is low. For example, in the
US, only 2% of cases with congenital hypothyroidism
are transient in nature, and the cause is mainly
attributed to transplacental transfer of maternal TSH
receptor–blocking antibodies.23
Maternal goitrogenesis and foetal
hypothyroidism
One of the subpopulations at risk for IDD is pregnant
women. Pregnancy increases the maternal requirement
for iodine intake. This is due to the increased renal
clearance of iodine from the kidney, as well as to the
transfer of iodine and iodothyronines to the foetus.24
Monodeiodination of iodothyronines within the
placenta also increases the demand for iodine as the
placenta enlarges. Previous studies conducted in
Europe revealed that a marginally low iodine intake of
<50 µg per day was sufficient to pose a significant
challenge to both the maternal and neonatal thyroid
gland, resulting in goitre formation in the mother and
hypothyroidism in the neonate.25
To evaluate the problem of dietary iodine insuffi-
ciency during pregnancy, a cross-sectional study of 253
healthy, southern Chinese pregnant women and their
neonates was conducted in Hong Kong in 1996.26
The results demonstrated the existence of border-
line iodine supply for many, with 35.8% of pregnant
women having a urinary iodine concentration below
0.79 µmol/L. This borderline iodine intake in pregnant
women had a significant effect on both maternal and
foetal thyroid function as evidenced by the following:
(1) a negative correlation between maternal serum
TSH concentra t ion and ur inary iodine
concentration;
(2) higher cord blood TSH levels in infants whose
mothers had a low urinary iodine concentration
compared with those whose mothers had normal
urine iodine concentrations; and
(3) women who had given birth to infants with a cord
blood TSH level ≥16 mU/L had lower urinary
iodine concentrations and serum free T4 levels
compared with those who had given birth to infants
with normal cord TSH levels, and their infants also
had higher cord blood thyroglobulin (Tg) levels.
To further evaluate the impact of iodine insuffi-
ciency in pregnant women and their neonates in Hong
Kong, a prospective study was undertaken.27 Two
hundred and thirty healthy women were studied from
the first trimester of pregnancy until 3 months after
delivery. Increased urinary iodine excretion was seen
from the first trimester onwards. There was a pro-
gressive reduction in circulating free T4, free T3
concentration, and free thyroxine index (FTI) with
increasing gestation, with subnormal levels at term of
53%, 61%, and 5%, respectively. Thyroid stimulating
hormone was increased two-fold at term. Overall,
thyroid volume (TV) as determined by ultrasonography
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was increased by 30% between the first and the third
trimester. Twenty-five percent of pregnant women at
term demonstrated goitre enlargement according to the
WHO definition of >18 mL. In contrast, studies
conducted in areas with adequate iodine intake due to
national dietary iodine supplementation programmes,
such as in the US, have shown no enlargement of the
thyroid gland or, at most, enlargement of <5% during
pregnancy.28 Furthermore, it has been noted that the
change in TV in women during pregnancy in the Hong
Kong study was correlated negatively with their urine
iodine concentration (r = –0.15, P<0.02) at term.28 Six
percent of these women showed excessive thyroidal
stimulation, as evidenced by a lower serum FTI and
higher Tg levels when compared with subjects without
evidence of thyroidal stimulation. In addition, these
subjects had lower urine iodine concentrations, a
lower serum FTI but higher Tg and free T3/free T4
ratios, as well as a larger TV throughout pregnancy.
Their neonates also had higher cord blood TSH, Tg,
and a slightly larger TV. Fifty percent of neonates had
subnormal free T4 at birth. Thus, pregnancy in a
borderline iodine-sufficient environment results in
maternal hypothyroxinaemia, maternal goitrogenesis,
as well as neonatal hypothyroxinaemia, hyperthyro-
tropinaemia, and thyroid hyperplasia.
Goitre incidence in children
Thyroid enlargement or goitre is the most prominent
consequence of iodine deficiency. The prevalence of
clinical goitre in school children has been widely
adopted as a population screening measure for iodine
deficiency,6 with a total goitre rate (TGR) of 5% or
more indicating that iodine deficiency is a public health
problem in that area. A study of school children in a
selected region of Hong Kong noted a TGR of 3.5%.16
On the basis of this finding alone, it seems that there is
no need for general iodine supplementation in Hong
Kong. However, although goitre and borderline iodine
deficiency do not appear to be prevalent in the school-
aged child, iodine deficiency clearly is a clinical issue
during later life, particularly during pregnancy and in
old age.
Hypothyroidism
Another circumstantial feature suggesting the possible
existence of iodine deficiency in Hong Kong is the
low prevalence of autoimmune thyroiditis and hypo-
thyroidism seen. The prevalence of elevated TSH
(>5 mU/L) in the elderly population has been reported
at only 1.0%,29 compared with 10% in Caucasians
residing in iodine-sufficient areas.24 Furthermore,
examination of thyroid function tests in the elderly
female population in Hong Kong revealed an increased
T3/T4 ratio and a rising trend in Tg with ageing.29 This
pattern of thyroid function test results is commonly
seen in situations where there is borderline thyroid
reserve associated with iodine insufficiency.
Epidemiological data show that differences in
iodine intake may affect the prevalence of autoimmune
thyroid disease. It has been reported that the prevalence
of autoimmune thyroid disease is low in regions with
low dietary iodine. Robuschi et al30 reported a low
prevalence (0.6%) of subclinical hypothyroidism in
Italy where there is low dietary iodine intake, com-
pared with a prevalence of 14% in the US, where the
dietary iodine intake is much higher. In Japan, where
there is a very high iodine intake, hypothyroidism is
very common and a positive correlation between the
prevalence of excess iodine intake and high serum TSH
has been found in various areas of Japan.31
Hyperthyroidism
The incidence and causes of hyperthyroidism in a
population can also reflect iodine intake. An epidemi-
ological study conducted in Denmark, found that
hyperthyroidism was significantly more common in
an area of low iodine intake compared with another
area with high iodine intake.32 Although the incidence
of Graves’ disease (GD) was similar in both areas, the
area with low iodine intake had significantly more cases
of multinodular toxic goitre—especially in elderly
women—resulting in significant morbidity, such as
cardiac arrhythmias, osteoporosis, and muscle wasting.
Unfortunately, data on the age-specific incidence of
various forms of hyperthyroidism is not available in
Hong Kong for comparison.
Elimination of iodine deficiency disorders in
Hong Kong
Overall, the collective evidence reviewed indicates that
the dietary iodine intake of the Hong Kong population
is borderline sufficient, but is inadequate to meet extra
requirements at times of thyroidal stress, such as during
pregnancy, neonatal, and pubertal growth. In addition,
this review makes clear that using goitre rates in
children only as an indicator may result in a serious
underestimation of the nature and magnitude of the
problem of IDD in many regions, including Hong
Kong.
It is important to recognise the existence of iodine
deficiency, however mild, during pregnancy. It has
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been shown that even a mild degree of maternal iodine
deficiency and maternal hypothyroidism during
pregnancy can result in poorer psychological and
neurological performance in the child, as well as
neonatal hypothyroidism.33-35 Transient low levels of
circulating thyroxine at the critical stage of brain
development in the newborn has been shown to result
in an intelligent quotient loss of 5 to 10 points.36
Iodine supplementation has to be early, as treatment
initiated in the third trimester can improve brain growth
and developmental achievement, but has no influence
on the neurological status of the affected child.3
Besides, early iodine supplementation can prevent
goitre development in both the pregnant mother and
the foetus.37 According to the WHO recommendations,
daily iodine intake for pregnant and lactating women
should be 200 µg per day.6
Iodine supplementation during pregnancy is
essential in Hong Kong because seafood is not com-
monly consumed.15 According to a dietary survey, 50
to 80% of subjects never consumed high iodine-
containing foods, such as seaweed, kelp, or laver, and
seafood intake was low in those subjects with low
iodine status. Infrequent consumption of iodine-
rich foods may stem from public ignorance of the
physiological functions of iodine and the devastating
consequences of its deficiency.38 There are only a
few places in the world that could ensure adequate
dietary iodine intake through natural food sources. The
majority of the world’s population achieve adequate
iodine intake through national supplementation
programmes, namely the iodisation of salt or other
vehicles.
Currently there is no programme to eliminate iodine
deficiency in Hong Kong due to the assumption that
IDD is non-existent, and the misconception that a high
incidence of thyrotoxicosis and thyroid cancer is related
to excessive iodine intake. In Hong Kong, the majority
of patients with thyrotoxicosis have GD. There is, in
fact, no published evidence to demonstrate that
increases in iodine intake cause GD. Current evidence
indicates:
(1) remission rates with antithyroid drug treatment of
GD are lower in areas with higher iodine intake39;
(2) the response to thionamide drugs is rapid in GD
patients who reside in IDD areas and the dose
required to control the disease is smaller40; and
(3) excess iodide administered to hyperthyroid patients
with GD increases TSH receptor–antibodies.41
It is possible that large quantities of iodides admin-
istered to patients with latent GD may result in frank
hyperthyroidism. However, there is to date no
published evidence to support this speculation.
With respect to thyroid cancer, the overall incidence
is not influenced by the iodine intake of the popu-
lation. However, the distribution of differing types of
thyroid carcinoma appears to be related to the intake
of iodine, with fewer of the more aggressive follicular
and anaplastic carcinomas, and more papillary carcin-
omas in iodine-rich areas. Populations commencing
iodine prophylaxis exhibit an increase in the ratio of
papillary to follicular carcinomas.42
There is also concern that an increase in iodine
intake may result in an increased incidence of thyroid
dysfunction—iodine-induced hyperthyroidism (IIH)43
and iodine-induced hypothyroidism.44 It has long been
known that thyrotoxicosis may develop in people with
normal thyroid glands when they are exposed to large
amounts of iodine, such as post-radio–contrast media
or with amiodarone treatment; and that thyroid function
may return to normal when the iodine is withdrawn.
Hyperthyroidism is seen in certain individuals residing
in low iodine intake regions when they are exposed
to an intake of iodine that is more than they are usually
accustomed to, particularly in the presence of existing
nodular changes in the thyroid gland.
An increased incidence of hyperthyroidism
following the introduction of iodised salt has been
reported in severely iodine-deficient countries.45
However, populations in these areas were exposed to
iodine excesses due largely to poor monitoring of the
quality of the iodised salt and of the iodine intake of
the population.43 The incidence of IIH during national
iodine prophylaxis programmes in many countries has
been low, and usually disappears several years after
the initiation of the programme.45 Iodine-induced
hyperthyroidism is most commonly encountered in
older people with long-standing nodular goitre, and in
regions of chronic iodine deficiency, but instances
of IIH in the young have also been reported.46 This
customarily occurs after an incremental rise in mean
iodine intake in the course of a national iodisation
programme, and is transient. Hence it should not
be regarded as a contraindication to an iodisation
programme, given the enormous long-term benefits of
the elimination of iodine deficiency on the whole
population, especially in the improvement in children’s
mental and physical health, as well as in women’s
health. With a systematic programme involving small
increments in the level of salt iodisation and close
monitoring of the programme, the problem of IIH can
be minimised.
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Contrarily, iodine-induced hypothyroidism,
through a habitual intake of large amounts of seaweed
(1-43 mg/d of iodine, ie 10-4300 times the daily iodine
requirement) was reported in Japan.44 Most hypo-
thyroidism is reversible, although severe cases may
be irreversible.47 Histologically, the thyroid gland
develops focal lymphocytic thyroiditis with a more
severe degree of destruction in these cases.
Overall, the iodine intake of the Hong Kong popu-
lation should be brought up to a level at which IDD
can be avoided but no higher. Health care policies are
urgently needed to establish intervention programmes
aimed at a relatively uniform iodine intake, avoiding
deficient or excessive iodine intake in subpopulations.
In the interim period, at-risk subpopulations including
pregnant and lactating women, and young children of
up to 3 years should receive physiological doses of
potassium iodate supplementation.
Conclusion
Iodine deficiency disorder is a major public health
problem worldwide. Although Hong Kong is not a
goitrous or an endemic iodine-deficient area, evidence
suggests the existence of mild iodine deficiency, which
can result in clinical IDD. A supplementation pro-
gramme aimed at a relatively uniform iodine intake is
recommended, to avoid deficient or excessive iodine
intake in subpopulations.
Acknowledgements
The authors wish to thank Ms K Yu for typing the
manuscript. The work is supported by the Hong Kong
Research Grant Council.
References
1. Hetzel BS. Mano MT. A review of experimental studies of
iodine deficiency during fetal development. J Nutr 1989;119:
145-51.
2. Hetzel BS. Iodine deficiency and fetal brain damage. N Engl J
Med 1994;331:1770-1.
3. Cao XY, Jiang XM, Dou ZH, et al. Timing of vulnerability of
the brain to iodine deficiency in endemic cretinism. N Engl J
Med 1994;331:1739-44.
4. Boyages SC, Collins JK, Maberly GF, Jupp JJ, Morris J,
Eastman CJ. Iodine deficiency impairs intellectual and
neuromotor development in apparently-normal persons. A
study of rural inhabitants of north-central China. Med J Aust
1989;150:676-82.
5. Delange F, Bourdoux P, Ermans AM. Neonatal thyroid
screening used as an index of an extraphysiological supply of
iodine. In: Hall R, Kobberling, editors. Thyroid disorders
associated with iodine deficiency and excess. New York: Raven
Press; 1985:273-382.
6. WHO/UNICEF/ICCIDD. Indicators for assessing iodine
deficiency disorders and their control through salt iodization.
WHO/NUT/94.6. Geneva: WHO; 1994.
7. Heywood PF, Marks GC. Nutrition and health in South-East
Asia. Med J Aust 1993;159:133-7.
8. Ma T, Guo J, Wang F. The epidemiology of iodine-deficiency
diseases in China. Am J Clin Nutr 1993;57(Suppl):264S-266S.
9. World Health Organization. Elimination of iodine deficiency
disorders in South-East Asia. New Delhi: WHO Regional
Office for South-East Asia; WHO Bulletin; 1997.
10. Joint FAO/WHO Expert Committee on Food Additives.
Geneva: World Health Organization; 1991. WHO Technical
Report Series, No. 806, Annex 5.
11. Wang YY, Yang SH. Improvement in hearing among otherwise
normal schoolchildren in iodine-deficient areas of Guizhou,
China, following use of iodized salt. Lancet 1985;2:518-20.
12. Zhao J, Xu F, Zhang Q, et al. Randomized clinical trial
comparing different iodine interventions in school children.
Public Health Nutr 1999;2:173-8.
13. Wang Y, Zhang H, Li XF, et al. An evaluation of the
effectiveness of the current salt-iodization programme in China
[in Chinese]. Zhong Guo Di Fang Bing Fang Zhi Za Zhi 1998;
13:332-4.
14. Excess iodine intake will cause goitre [in Chinese]. Choice
Magazine 1998;264:4-19.
15. Kung AW, Chan LW, Low LC, Robinson JD. Existence of
iodine deficiency in Hong Kong—a coastal city in southern
China. Eur J Clin Nutr 1996;50:569-72.
16. Wong GW, Lam CW, Kwok MY, et al. Childhood goitre and
urinary iodine excretion in Hong Kong. Eur J Pediatr 1998;
157:8-12.
17. Low LC, Lin HJ, Cheung PT, et al. Screening for congenital
hypothyroidism in Hong Kong. Aust Paediatr J 1986;22:53-6.
18. Delange F, Burgi H. Iodine deficiency disorders in Europe.
Bull World Health Organ 1989;67:317-25.
19. Delange F, Bourdoux P, Laurence M, Peneva L, Walfish P,
Willgerodt H. Neonatal thyroid function in iodine deficiency.
In: Delange F, Dunn JF, Glinoer D, editors. Iodine deficiency
in Europe—a continuing concern. New York: Plenum Press;
1993:199-207.
20. Fisher DA, Burrow GN, Dussault JH, et al. Recommendations
for screening programs for congenital hypothyroidism. Report
of a committee of the American Thyroid Association. Am J
Med 1976;61:932-4.
21. Lo KK, Lam ST. Neonatal screening programme for congenital
hypothyroidism in Hong Kong. In: Lam ST, Pang CC, editors.
Neonatal and perinatal screening: the Asian Pacific
perspectives. Hong Kong: The Chinese University Press; 1996:
145-8.
22. Kung AW, Low LC. Thyrotrophin-blocking antibodies in
congenital hypothyroidism. J Paediatr Child Health 1992;28:
50-3.
23. Brown RS, Bellisario RL, Botero D, et al. Incidence of transient
congenital hypothyroidism due to maternal thyrotropin
receptor-blocking antibodies in over one million babies. J Clin
Endocrinol Metab 1996;81:1147-51.
24. Burrow GN, Fisher DA, Larsen PR. Maternal and fetal thyroid
function. N Engl J Med 1994;331:1072-8.
25. Glinoer D. The regulation of thyroid function in pregnancy:
pathways of endocrine adaptation from physiology to
pathology. Endocr Rev 1997;18:404-33.
26. Kung AW, Lao TT, Low LC, Pang RW, Robinson JD. Iodine
insufficiency and neonatal hyperthyrotropinaemia in Hong
Kong. Clin Endocrinol (Oxf) 1997;46:315-9.
420      HKMJ Vol 7 No 4 December 2001
Kung et al
27. Kung AW, Lao TT, Chau MT, Tam SC, Low LC. Goitrogenesis
during pregnancy and neonatal hypothyroxinaemia in a
borderline iodine sufficient area. Clin Endocrinol (Oxf) 2000;
53:725-31.
28. Berghout A, Endert E, Ross A, Hogerzeil HV, Smits NJ,
Wiersinga WM. Thyroid function and thyroid size in normal
pregnant women living in an iodine replete area. Clin
Endocrinol (Oxf) 1994;41:375-9.
29. Kung AW, Janus ED. Thyroid dysfunction in ambulatory
elderly Chinese subjects in an area of borderline iodine intake.
Thyroid 1996;6:111-4.
30. Robuschi G, Safran M, Braverman LE, Gnudi A, Roti E.
Hypothyroidism in the elderly. Endocr Rev 1987;8:142-53.
31. Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K. Association
between dietary iodine intake and prevalence of subclinical
hypothyroidism in the coastal regions of Japan. J Clin
Endocrinol Metab 1994;78:393-7.
32. Laurberg P, Nohr SB, Pedersen KM, et al. Thyroid disorders
in mild iodine deficiency. Thyroid 2000;10:951-63.
33. Man EB. Maternal hypothyroxaemia: development of 4- and
7- year old offspring. In: Fisher DA, Burrow GN, editors.
Perinatal thyroid physiology and disease. New York: Raven
Press; 1975:117-32.
34. Pharoah PO, Connolly KJ, Ekins RP, Harding AG. Maternal
thyroid hormone levels in pregnancy and the subsequent
cognitive and motor performance of the children. Clin
Endocrinol (Oxf) 1984;21:265-70.
35. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid
deficiency during pregnancy and subsequent neuro-
psychological development of the child. N Engl J Med 1999;
341:549-55.
36. Calaciura F, Mendorla G, Distefano M, et al. Childhood IQ
measurements in infants with transient congenital
hypothyroidism. Clin Endocrinol (Oxf) 1995;43:473-7.
37. Glinoer D, De Nayer P, Delange F, et al. A randomized trial
for the treatment of mild iodine deficiency during pregnancy:
maternal and neonatal effects. J Clin Endocrinol Metab 1995;
80:258-69.
38. Lellep Fernandez R. Biocultural belief and iodine prophylaxis.
Soc Sci Med 1988;27:587-96.
39. Solomon BL, Evaul JE, Burman KD, Wartofskly L. Remission
rates with antithyroid drug therapy: continuing influence of
iodine uptake? Ann Intern Med 1987;107:510-2.
40. Azizi F. Environmental iodine intake affects the response to
methimazole in patients with diffuse toxic goiter. J Clin
Endocrinol Metab 1985;61:374-7.
41. Wilson R, McKillop JH, Thomson JA. The effect of pre-
operative potassium iodide therapy on antibody production.
Acta Endocrinol (Copenh) 1990;123:531-4.
42. Feldt-Rasmussen U. Iodine and cancer. Thyroid 2001;11:
483-6.
43. Stanbury JB, Ermans AE, Bourdoux P, et al. Iodine-induced
hyperthyroidism: occurrence and epidemiology. Thyroid 1998;
8:83-100.
44. Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K. Association
between dietary iodine intake and prevalence of subclinical
hypothyroidism in the coastal regions of Japan. J Clin
Endocrinol Metab 1994;78:393-7.
45. Kobberling J, Hintze G. Diagnostic problems in iodine induced
thyrotoxicosis. In: Hall R, Kobberling J, editors. Thyroid
disorders associated with iodine deficiency and excess. New
York: Raven Press; 1993:419.
46. Dunn JT, Semigran MJ, Delange F. The prevention and
management of iodine-induced hyperthyroidism and its cardiac
features. Thyroid 1998;8:101-6.
47. Tajiri J, Higashi K, Morita M, Umeda T, Sato T. Studies of
hypothyroidism in patients with high iodine intake. J Clin
Endocrinol Metab 1986;63:412-7.
